Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9 by Bopp, Selina ER et al.
 Identification of the Plasmodium berghei resistance locus 9 linked
to survival on chromosome 9
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Bopp, Selina ER, Evelyn Rodrigo, Gonzalo E González-Páez,
Mary Frazer, S Whitney Barnes, Clarissa Valim, James Watson,
John R Walker, Christian Schmedt, and Elizabeth A Winzeler.
2013. “Identification of the Plasmodium berghei resistance locus
9 linked to survival on chromosome 9.” Malaria Journal 12 (1):
316. doi:10.1186/1475-2875-12-316.
http://dx.doi.org/10.1186/1475-2875-12-316.
Published Version doi:10.1186/1475-2875-12-316
Accessed February 19, 2015 2:58:29 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879277
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Bopp et al. Malaria Journal 2013, 12:316
http://www.malariajournal.com/content/12/1/316RESEARCH Open AccessIdentification of the Plasmodium berghei
resistance locus 9 linked to survival on
chromosome 9
Selina ER Bopp1,4*, Evelyn Rodrigo2, Gonzalo E González-Páez3, Mary Frazer2, S Whitney Barnes2, Clarissa Valim4,
James Watson2, John R Walker2, Christian Schmedt2 and Elizabeth A Winzeler1Abstract
Background: One of the main causes of mortality from severe malaria in Plasmodium falciparum infections is
cerebral malaria (CM). An important host genetic component determines the susceptibility of an individual to
develop CM or to clear the infection and become semi-immune. As such, the identification of genetic loci
associated with susceptibility or resistance may serve to modulate disease severity.
Methodology: The Plasmodium berghei mouse model for experimental cerebral malaria (ECM) reproduces several
disease symptoms seen in human CM, and two different phenotypes, a susceptible (FVB/NJ) and a resistant mouse
strain (DBA/2J), were examined.
Results: FVB/NJ mice died from infection within ten days, whereas DBA/2J mice showed a gender bias: males
survived on average nineteen days and females either died early with signs of ECM or survived for up to three
weeks. A comparison of brain pathology between FVB/NJ and DBA/2J showed no major differences with regard to
brain haemorrhages or the number of parasites and CD3+ cells in the microvasculature. However, significant
differences were found in the peripheral blood of infected mice: For example resistant DBA/2J mice had
significantly higher numbers of circulating basophils than did FVB/NJ mice on day seven. Analysis of the F2
offspring from a cross of DBA/2J and FVB/NJ mice mapped the genetic locus of the underlying survival trait to
chromosome 9 with a Lod score of 4.9. This locus overlaps with two previously identified resistance loci (char1 and
pymr) from a blood stage malaria model.
Conclusions: Survival best distinguishes malaria infections between FVB/NJ and DBA/2J mice. The importance of
char1 and pymr on chromosome 9 in malaria resistance to P. berghei was confirmed. In addition there was an
association of basophil numbers with survival.
Keywords: Plasmodium berghei, Experimental cerebral malaria, Quantitative trait locus, Malaria, Basophil,
Chromosome mapping, MouseBackground
The majority of infectious disease deaths worldwide are
due to malaria, HIV and tuberculosis and malaria is the
most common parasitic disease in the world. Five mal-
aria parasite species can cause malaria in humans with
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reproduction in any medium, provided the ordeaths that result from the severe form of disease. Severe
malaria is characterized by anaemia, respiratory distress,
and cerebral malaria (CM). Many factors contribute to
the manifestation of CM. Cytoadherence of infected red
blood cells (RBCs) in brain micro-vessels and other
organs; parasite products such as toxins and possibly
haemozoin; local and systemic production of cytokines
and chemokines by the host; the activation, recruitment
and infiltration of inflammatory cells are also involved in
the development of CM and the neurological symptoms
[1]. Although parasite sequestration, haemorrhage andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CM is not a homogenous syndrome. Variations in the
clinical features of CM may be due to genetic differences
in the host or the parasite, the immune response of the
patient and/or environmental factors.
For ethical and logistical reasons CM can only be stud-
ied using brains from fatal cases (not during the course
of an infection or after successful treatment). Primate
models of CM, such as Plasmodium knowlesi and Plas-
modium coatneyi infections in Rhesus monkeys [2,3]
and P. falciparum infections in squirrel monkeys [4]
exist; however, these are expensive and use of non-
human primates are problematic. The Plasmodium ber-
ghei ANKA mouse model of experimental cerebral mal-
aria (ECM) replicates most of the human CM symptoms
and is the most commonly used model for CM [5,6].
Susceptible mouse strains such as CBA and C57BL/6 de-
velop ECM with ataxia, paralysis, and coma [7]. Blood
brain barrier disruption and vascular leakage are also ob-
served in mice with ECM [8,9] as well as accumulation
of platelets [10,11], monocytes and macrophages in the
micro-vessels [12,13]. Other mouse strains do not show
symptoms of ECM [14,15].
It is now an established fact that the genetic back-
ground of the host can influence the outcome of disease.
For example, coevolution of the parasite and the host
has led to an increase of beneficial alleles in malaria en-
demic areas. These include sickle cell trait (HbAS) and
haemoglobinopathies such as thalassaemias and glucose-
6-phosphate dehydrogenase deficiency as well as a
number of immune-modulating genes that have been as-
sociated with resistance or susceptibility to P. falciparum
malaria in humans (reviewed in [16]). Linkage and gene
association studies in humans are hampered by the need
for large number cases and controls. Genome-wide ana-
lysis in inbred mouse strains eliminates genetic variabil-
ity between individuals and serves as a model to study
resistance and susceptibility to Plasmodium in a well-
defined system. To date, ten genetic loci that contribute
to the control of parasitaemia have been identified in
Plasmodium chabaudi infections (char1-11) [17-25].
Similarly, seven genetic loci associated with resistance to
ECM (berr1, berr2, berr5, berr6, berr7, cmsc and a locus
on chromosome 18) [26-31] and one locus associated
with reduced liver infection (belr1) have been mapped
using the P. berghei model [32]. An additional locus
(berr3) was identified that controlled resistance to lethal
infection and one locus that enhanced survival time
(berr4) [29]. A combinatorial effect of loci berr1 and
berr3 was suggested to be responsible for the clearance
of parasites and survival [29,33].
In a previous study, 32 different mouse strains were
characterized for survival, body temperature and parasite
distribution in organs. Survival was mapped to a sixthberghei resistance locus (berr6) containing the peroxi-
some proliferator-activated receptor gamma (Pparg)
using haplotype associated mapping (HAM) [15]. In this
study, a susceptible (FVB/NJ) and a resistant (DBA/2J)
mouse strain were characterized in more detail to iden-
tify early predictors of disease. Survival was the most ro-
bust resistance trait and a whole genome scan identified
chromosome 9 as a key regulator for survival in a F2
cross. Genes in the locus identified in this study might
be potential targets for therapeutic interventions.
Methods
Ethic statement
All animal experiments were approved by the Institu-
tional Animal Care and Use Committee (IACUC) and
conducted in agreement with the NIH policy.
Mice
The DBA/2J and FVB/NJ inbred strains were purchased
from The Jackson Laboratories (JAX). Eight to twenty
week-old mice were used in the study. Mice were housed
in a pathogen free facility at the Genomics Institute of
the Novartis Research Foundation (GNF) and all experi-
ments were approved by the IACUC and conducted in
agreement with the NIH policy.
Genotyping
Before infection, tail biopsies were obtained from all F2
animals and genomic DNA was isolated by a standard
procedure involving proteinase-K treatment [34]. Mice
were genotyped for a total of 355 SNPs and microsatel-
lite markers. SNP genotyping was performed at GNF by
using the Sequenom MassARRAY system and a custom
panel of SNPs distributed across the genome [35].
Infection and parasites
Plasmodium berghei ANKA strain PbGFP–LUCSCH [36]
was used for all infections. Parasites from frozen stocks
of this strain were propagated and maintained in donor
mice. Mice were infected intraperitoneally with 1×106-
parasitized red blood cells obtained from a donor mouse.
Parasites were preserved in Alsever’s solution containing
10% glycerol and stored in liquid nitrogen.
Parasitaemia
Parasite levels in the blood were monitored by flow cy-
tometry analysis. Blood was obtained from the tip of the
tail: the end of the tail was clipped with a clean razor
and ~5 μl of whole blood was fixed in 1 ml of 0.25%
glutaraldehyde in PBS (pH 7.4) and stored at 4°C before
being stained. For subsequent bleeds the scab was re-
moved. Fixed blood was incubated for 1 h at 37°C in the
dark with 1 μM Hoechst 33258 in PBS. The samples
were analysed by cytofluorometry using a FACStar plus
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with a Coherent Innova 90 laser tuned to UV excitation
(351 nm, 200 mW). A 424DF44 filter was selected as the
emission filter for the blue Hoechst fluorescence. Files
were analysed by Cellquest 3.2 software. Erythrocytes
were gated by forward and side scatter and subse-
quently infected erythrocytes were selected by gating
for Hoechst fluorescence. For each sample, 3,000 events
were acquired and recorded. The percentage of infected
RBCs was determined on the basis of the positive blue
fluorescence of infected erythrocytes.ECM scores
Mice were monitored twice a day, starting three days
post infection, and clinical ECM evaluated. The score
recorded later during the day was used for the ECM
progression per day when different from the earlier score
of the same day. Clinical ECM scores were defined by
the presentation of the following signs: ruffled fur,
hunching, wobbly gait, limb paralysis, convulsions, and
coma. Each sign was given a score of 1. Additionally, a
score of 0.5 was given if the mice were unresponsive
to touch and too weak to stand without paralysis or
convulsions. Animals with severe ECM (accumulative
scores > 3.5) were sacrificed by isoflurane asphyxiation
according to ethics guidelines, and survival was deemed
to be the same day due to the rapid progress of the
disease.Evans blue
200 μl 1% Evans blue dye were injected into each mouse
via the tail vein. After 1 h the mouse was euthanized
with isoflurane, and subsequently the brain was removed
and placed in 1 ml formalin for 48 h at room tem-
perature to extract the Evans blue dye. The optical density
of the extracted dye was measured with a SPECTRAmax
PLUS ROM v3.13 fluorescence plate reader in the absorb-
ance mode at 620 nM. The absorbance for the extracted
dye from an infected brain was normalized to the dye
extracted from an uninfected control brain prepared on
the same day.Complete blood count
Mice were lightly anesthetized with isoflurane and 70 μl
blood was collected from the eye by retro-orbital blee-
ding. Blood was diluted 1:3 in CELL-DYN solution and
mixed for 10 min on a tube-roller and subsequently
analysed in a CELL-DYN 3700 multi-parameter haema-
tology analyzer (Abbott, IL, USA) according to the man-
ufacturer’s instructions. Since control mice did not show
significant differences between day two and seven by
paired student t test their values were pooled.Histology
After dissection, the brains were bisected sagittally along
the midline, half were fixed in 10% formalin then em-
bedded in paraffin, and the other half were fixed in 4%
paraformaldehyde, embedded in Tissue-Tek OCT (Sakura
Finetek USA, Inc., CA, USA) and then frozen. Paraffin
embedded brains were serially sectioned in the sagittal
plane at 5 microns. Every 10th slide was stained with
haematoxylin-eosin (H&E) and the adjacent slide was
stained with Giemsa. Sections were also stained with anti-
CD3 and anti-GFP antibodies on a Ventana Staining
platform. After deparaffinization, heat induced antigen re-
trieval, avidin/biotin blocking, and serum blocking the
slides were incubated with the following antibodies: CD3
(Cat#A0452, Dako, CA, USA) and GFP (Cat# LS-C67081,
LifeSpan BioSciences, Inc., WA, USA). Species appropri-
ate biotinylated secondary antibody was applied and 3,3′
diaminobenzidine (DAB) chromogen detection was used.
Statistical analysis
Quantitative trait locus was performed using the R/QTL
software [37]. This software calculates the logarithm of
odds (Lod) scores over intervals between linked markers,
representing the likelihood of genetic linkage of quanti-
tative phenotypes with markers along the chromosome.
The hidden Markov methodology technology was used
to calculate the probabilities of the true underlying ge-
notypes given the observed multipoint marker data, with
possible allowance for genotyping errors. The Viterbi al-
gorithm filled in missing genotypes and subsequently
marker regression analysis was performed. The level of
statistical significance was empirically determined by
permutation tests (1,000). Markers and mouse IDs for
which more than 80% of the samples showed no good
signal were not considered. Statistical significance of dif-
ferences in survival between FVB/NJ and DBA/2J mice
were assessed through partial likelihood ratio tests esti-
mated via Cox proportional-hazards models. Since those
differences in survival could not only be confounded by
strain, but also vary according to mouse gender, in Cox
models, results were adjusted by gender and compared
survival across genders by testing interaction terms be-
tween gender and strain. The same approach was used
to compare survival of male and female F2 mice.
Comparisons of changes over time in body weight,
parasitaemia (natural log transformed percent parasit-
aemia with a constant), and ECM between FVB/NJ and
DBA/2J were done in linear regression models with a
random intercept to account for within mice correlation
across days. These models tested whether slopes of
linear trends of FVB/NJ and DBA/2J were statistically
significantly different (through inclusion of an inter-
action term between strain and day) before and after ac-
counting for the effect of gender at day 0 (baseline).
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between FVB/NJ and DBA/2J mice for both genders
through inclusion of interaction terms. Model selection
was based on F-tests.
A student’s t test was used to check strain specific statis-
tically significant differences for parasitaemia and body
weight on specific days. A Mann-Whiney-Wilcoxon Rank
Sum test was used to calculate daily differences in ECM
scores. Differences between control mice and infected
mice regarding haematocrit, blood composition and
absorbance of Evan’s blue were assessed by one-way
ANOVA analysis with a Dunnett’s post-hoc test.
In all tests, p-values were considered statistically sig-
nificant if ≤ 0.05, except when studying interactions with
gender in which p-values ≤ 0.10 were considered bor-
derline significant and yield reporting of gender specific
associations. Statistically significant differences were cal-
culated in GraphPad Prism and Splus 8.0.
Results
Phenotypic differences between DBA/2J and FVB/NJ mice
To identify the gene regions responsible for susceptibi-
lity or resistance to ECM caused by P. berghei infection,
the phenotype that best distinguishes a susceptible and a
resistant mouse strain or that allows early prediction of
severity of disease was assessed. To date only C57BL/6
mice have been used in combination with a resistant0
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other susceptible mouse strain might give new insight
into the disease, a susceptible FVB/NJ and a resistant
DBA/2J mouse strains were used for this analysis [15].
Since body temperature and parasite load in organs
were not as informative as survival in earlier studies
[15], additional phenotypes such as signs of ECM, para-
sitaemia, body weight and haematocrit were included in
this study. In previous studies DBA/2J mice presented a
resolving phenotype of ECM where mice showed signs
of ECM early during infection but recovered and died of
high parasitaemia late during infection [38]. Therefore,
ten male and ten female DBA/2J mice and four male
and four female FVB/NJ mice were infected. All FVB/NJ
mice died within nine days of infection, and differences
in the rate of death of DBA/2J and FVB/NJ mice were
statistically significantly different before (p < 0.001) and
after accounting for the effect of gender (p < 0.001).
Overall, there was no significant difference in survival
between males and females (p = 0.143). Surprisingly,
DBA/2J mice did not show a resolving phenotype of
ECM: seven female and one male DBA/2J died before
day eleven and the remaining DBA/2J survived for thir-
teen days or longer (Figure 1A). As a consequence the
DBA/2J mice were put into two groups: in the sus-
ceptible group mice died before day thirteen and in the
resistant group mice survived for thirteen days andD
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nine males, however survival in DBA/2J females was not
statistically significantly different from survival in DBA/
2J mice (p = 0.15).
Loss of body weight is a general feature of most mouse
malaria infections [39]. To determine whether weight
loss was a valid predictor of disease severity or survival,
mice were weighed daily. Both strains showed a signifi-
cant drop in body weight from day seven onwards, re-
gardless of disease symptoms (FVB/NJ p = 0.0068 and
DBA/2J p = 0.0001, Figure 1B). Changes in body weight
over time from day five on were significantly diffe-
rent between FVB/NJ and DBA/2J mice (p = 0.01). This
most likely resulted from a significant difference in
changes in body weight over time between DBA/2J and
FVB/NJ females (p = 0.01) rather than males (p = 0.27)
(p interaction term = 0.03). The weight of DBA/2J mice
decreased to below 70% of their initial weight. Total
weight loss correlated with survival in DBA/2J mice but
the onset of loss in body weight was similar for both
strains and only different for DBA/2J females. Therefore
weight loss was not used as a predictor of severity of
disease.
Parasitaemia was measured every second day starting
on day three post infection. As expected parasitaemia in-
creased over the course of infection and there was a
positive correlation between survival and terminal para-
sitaemia in both strains (FVB/NJ: r = 0.751, p = 0.0317,
DBA/2J: r = 0.7153, p = 0.0004, Figure 1C). Changes in
parasitaemia over time from day five on between strains
were statistically significant (p before and after adjust-
ments by gender < 0.0001) and results were not affected
by gender (p = 0.80); comparison between genders was
borderline significant (p = 0.06). The parasitaemia was
significantly higher in FVB/NJ mice on day seven than
in DBA/2J mice (p = 0.0045) suggesting that initially
DBA/2J mice control parasitaemia better than FVB/NJ
mice. Nevertheless, DBA/2J mice are not able to control
parasitaemia and hyper parasitaemia is a likely cause
of death for the mice that survived for more than
thirteen days.
Anaemia is a major symptom of severe disease in
humans and mice. The haematocrit is a direct way to
measure anaemia. To measure the onset of anaemia the
haematocrit was measured on day two and day seven of
the infection. There was a significant decrease in the
haematocrit of FVB/NJ mice on day seven compared to
the uninfected control; however, there was no significant
decrease in DBA/2J mice, indicating a genetic difference
between the two strains (Figure 1D). There were no sig-
nificant gender specific differences within or between
strains. No correlation between the haematocrit and the
parasitaemia on day seven was observed indicating that
haemolysis of infected red blood cells was probably notresponsible for the drop in haematocrit. Surprisingly,
survival in DBA/2J mice was negatively correlated with
haematocrit on day seven (r = −0.5046, p = 0.0327). As
such this implies that anaemia was not the cause of
death for the eight DBA/2J mice that died early.
Out of all assessed phenotypes only loss of body
weight was affected by gender and gender specific ge-
netic factors were therefore not operating to generate
phenotypic differences.
Haemorrhage in the brain is insufficient to induce ECM
When infected with P. berghei ANKA parasites, certain
mouse strains such as C57BL/6 and CBA, develop symp-
toms of ECM including ataxia, fitting, respiratory dis-
tress and coma [7]. The conditions worsen quickly and
oftentimes death occurs within four to five hours of the
onset of neurological signs. Disruption of the blood
brain barrier and vascular leakage have been observed in
brains of mice showing signs of ECM. To determine
whether FVB/NJ or DBA/2J mice succumb to ECM, the
mice were examined twice daily and symptoms of ECM
were scored as following: 1: ruffled fur, 2: hunching, 3:
wobbly gate, 3.5 no response to touch, 4: limb paralysis,
5: seizure and 6: coma. ECM scores increased rapidly in
the FVB/NJ mice, moderately in the susceptible DBA/2J
mice and slowly in the resistant DBA/2J mice. This ex-
plains the initial increase followed by a drop in ECM
scores in the DBA/2J mice (Figure 2A). There were sig-
nificant differences in ECM trends over time between
the strains (p before and after accounting for the baseline
effect of gender < 0.001) but those differences were com-
parable in males and females (p = 0.45). All FVB/NJ mice
had scores of 2 and more on day eight in comparison to
30% of the DBA/2J mice. Only one FVB/NJ mouse and
two DBA/2J mice were either paralyzed or had seizures.
None of the DBA/2J mice that survived for over thirteen
days had scores higher than 3.5 indicating that only those
mice that died early had severe signs of ECM.
Since only a small fraction of the mice showed strong
signs of ECM, the extent of ECM was further investi-
gated in these strains. The degree of vascular leakage in
brains of FVB/NJ and DBA/2J mice was investigated
with Evans blue. Mice that had ECM scores of 3.5 and
higher were injected with Evans blue into the tail vein
and the absorption of Evans blue in the brain was mea-
sured (Figure 2B). The blood vessels of brains from con-
trol mice were red indicating that the blood–brain
barrier had not been disrupted and Evans blue did not
cross the blood–brain barrier. In contrast, blood vessels
of mice infected with P. berghei were stained blue and
infected mice had significantly higher absorption of
Evans blue than the uninfected control mice. All of the
brains from infected mice were stained blue and there
was no significant difference of Evans blue absorption
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of the amount of leakage of Evans blue into the brain
with survival or ECM scores. While only three mice
showed strong signs of ECM such as paralysis or sei-
zures, leakage of blood into the brain was observed
in all thirteen mice confirming that high ECM scores
are associated with break down of the blood brain
barrier.Accumulation of parasites and T cells in brain vessels is
not associated with severity of disease
As vascular leakage was found in brains of both strains,
differences in the brains of susceptible and resistant
mice was further investigated early during infection. Se-
questration of mature parasites in peripheral tissue by
cytoadherence of infected RBCs to the vascular endothe-
lium is a common feature of P. falciparum malaria. Se-
questration of parasites in the brain is observed in
humans, as well as in mice, but its contribution to CM
remains controversial (reviewed in [40]). Six brains of
male mice on day eight, when FVB/NJ mice had started
to show signs of ECM and the DBA/2J males had not,
were examined. To more closely mimic the conditions
found in human brains after autopsy, mice were not per-
fused prior to dissection. For general morphological dif-
ferences brain sections were stained with H&E and
Giemsa. The blood vessels contained infected RBCs and
there was a marked increase in the amount of leukocytes
present in brains from infected mice, compared to the
controls (Figure 3). There was no obvious difference be-
tween the FVB/NJ and the DBA/2J mice.
The P. berghei strain used in this study carried a GFP
protein under the control of an apical membrane associ-
ated 1 gene promoter that is expressed in schizonts and
early rings [41]. Therefore, anti GFP antibodies were
used to detect the parasite load in the brain. The stain-
ing of GFP confirmed the presence of parasites in the
brains of infected mice from both strains (Figure 3). In
addition to sequestration of parasites in the brain there
is also an accumulation of lymphocytes (mainly CD8 T
cells) in the brain of infected mice (reviewed in [42]). To
specifically detect the amount of T cells in the brains,
sections were stained with anti-CD3 antibodies. Although
there were almost no T cells present in uninfected brains,
brains from FVB/NJ and DAB/2-J mice showed massive
infiltration (Figure 3). Anti-CD3 antibodies stained the
majority of the nucleated cells and therefore most of the
leukocytes observed in Giemsa and H&E stains were T
cells. Again, no obvious difference in lymphocyte numbers
between FVB/NJ and DBA/2J mice was found. Thus the
presence of parasites and leukocytes (mainly T cells) in
the brain is not correlated with CM or early death in
FVB/NJ mice.
Figure 3 Histological analysis of mouse brains. Brains from three infected male FVB/NJ and DBA/2J, and from control mice were prepared for
histological analysis on day eight post-infection. Shown are representative images for sagittal brain sections that were stained with Giemsa or
E&H for general brain pathology (first two rows). Parasites used in the infection express GFP and were visualized with an anti-GFP antibody (third
row) and lymphocytes with an anti-CD3 antibody (last row). Arrowheads indicate infected red blood cells and arrows indicate leukocytes.
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associated with resistance
Because no major differences were found in brains from
mice that died early compared to mice that survived lon-
ger, the peripheral blood composition was examined in
uninfected mice as well as infected mice on days two
and seven post-infection. Significant differences between
the uninfected parental control mice were observed:
FVB/NJ control mice had significantly higher platelet
counts than DBA/2J control mice and significantly lower
basophil and monocyte counts than DBA/2J control
mice (Figure 4).
Changes in the blood composition over the course of
infection were observed for infected mice compared to
their strain-specific uninfected control mice. Both strains
showed a significant reduction in the number of platelets
on day seven although the reduction was greater in
FVB/NJ mice (8.5) than in DBA/2J mice (3.7). The total
white blood cell (WBC) count also decreased signifi-
cantly in both strains during the course of infection.
FVB/NJ mice showed a significant decrease on day two
whereas WBC counts did not drop significantly in DBA/
2J mice until day seven. The same was true for lympho-
cytes, which account for the majority of WBC in control
mice (94% in FVB/NJ and 89% in DBA/2J). This is incontrast to the accumulation of CD3 positive lympho-
cytes in the brain on day seven seen by histology.
Sequestration of lymphocytes in the brain and other or-
gans might be the reason for the reduction of lympho-
cytes in the peripheral blood.
As the DBA/2J mice consisted of those that were re-
sistant (i.e. survived for over thirteen days) and suscep-
tible (i.e. died before day thirteen), their peripheral blood
composition was compared on day seven separately as
well. Eosinophils increased significantly in FVB/NJ mice
on day seven as well as in susceptible but not resistant
DBA/2J mice (Figure 4). There was a significant negative
correlation between eosinophil counts on day seven and
survival in DBA/2J mice (r = −0.69, p = 0.0007). Al-
though there was no change in neutrophil counts in
FVB/NJ mice, susceptible DBA/2J mice showed a signi-
ficant increase and neutrophil counts on day seven corre-
lated inversely with survival for DBA/2J mice (r = −0.81, p
> 0.00001). Monocytes increased significantly on day
seven in both strains however the increase was signifi-
cantly higher in resistant DBA/2J mice than in susceptible
mice. The overall increase in monocytes was higher in
FVB/NJ (7.2) than in DBA/2J (5.7) but this increase in
monocytes did not seem to protect the mice from early
death and there was only a weak correlation between
monocytesbasophils
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mice (r = 0.55, p = 0.0114). Although basophil numbers on
day seven decreased in FVB/NJ and susceptible DBA/2J
mice they increased significantly in resistant DBA/2J mice.
There was a strong correlation between basophil counts
on day seven and survival in DBA/2J mice (r = 0.796, p <
0.0001). Susceptible mice of both strains behaved similar
in the dynamics of WBC and platelets during the course
of infection with the exception of basophils. While baso-
phil counts on day seven dropped in susceptible mice
from both strains, resistant mice showed an increase.
Therefore, an increase in basophils on day seven was asso-
ciated with protection from early death.
Survival is linked to a locus on chromosome 9
To determine a genetic component that might be re-
sponsible for the early death of FVB/NJ mice and the
bimodal survival distribution in DBA/2J, the F2 gener-
ation of a cross between the FVB/NJ mice and the DBA/
2J mice was analysed. Parasitaemia, ECM scores and sur-
vival for 175 F2 mice as well as twelve DBA/2J and nine
FVB/NJ control mice were recorded (Figure 5).
The survival distribution was also bimodal in the F2
generation, with a median survival of eight days for mice
that died before day thirteen and a median of 20 days
for mice that died after day thirteen. Survival was notlinked to gender in the F2 generation (Figure 5A B and
C) as there was no significant difference in survival
between F2 males and females (p = 0.66). The linear
slope of the parasitaemia of the F2 mice was not signifi-
cantly different from that of the parents (Figure 5D, p
before and after accounting for the baseline effect of
gender was 0.44 and 0.53, respectively) and the terminal
parasitaemia correlated also with survival (r = 0.796, p <
0.0001). The significant difference in parasitaemia seen
previously between FVB/NJ and DBA/2J mice on day
seven was not observed. The increase in F2 ECM scores
was comparable to the DBA/2J parental mice with a
steep increase in ECM in susceptible mice and a slower
increase in resistant mice (Figure 5E). There was a bor-
derline significant difference in the linear part of the
slope of the ECM curve for the F2 mice compared to
the parental mice (p = 0.08). The degree of ECM was
higher in the F2 mice where 28% had ECM scores of
more than 3.5 compared to their parents (10% in DBA/
2J and 12.5% in FVB/NJ). 84% of these high ECM scores
occurred in mice that died before day thirteen. Even
though mice were checked three times daily, 48% of the
F2, 73% of FVB/NJ and 85% of DBA/2J mice were found
dead. It is therefore possible that a number of these mice
would have progressed to severe disease and the ter-
minal ECM scores might have been higher. Due to this
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http://www.malariajournal.com/content/12/1/316uncertainty and the fact that there was no difference in
parasitaemia, the survival trait was chosen as the
most robust trait for quantitative trait locus analysis
(QTL).
To identify the QTL underlying the survival pheno-
type, all F2 mice were genotyped for 355 informative
markers across all chromosomes. Quantitative trait ana-
lysis was performed in Rqtl across all chromosomes with
survival as a quantitative trait. Only mice and markers0
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chabaudi [17,24,25]. It also overlaps with a locus called
Pymr, (89.9 to 118.8 Mb) associated with resistance of
mice to Plasmodium yoelii infections [43]. These findings
strengthen the importance of this locus in the develop-
ment of host resistance in murine malaria.
Discussion
In depth characterization of FVB/NJ, a new mouse strain
for malaria research, and DBA/2J, another strain used in
malaria research, revealed similarities in the brain path-
ology between the strains but with differences in the
peripheral blood composition. Mapping of the survival
phenotype in a F2 cross identified a new locus on
chromosome 9 that overlaps with a locus associated with
parasite control in P. chabaudi (char1) and a locus iden-
tified in the P. yoelii parasitaemia model (pymr).
Rupture of the blood brain barrier and haemorrhage
in the brain has been associated with susceptibility to
ECM while being absent in ECM resistant mouse strains
[45,46]. However, similar amounts of leakage of Evans
blue into brains from resistant as well as susceptible
mice were detected. In contrast, uninfected mice did not
show leakage of Evans blue into the brain, suggesting
that brains of infected mice differed in the permeability
of the dye into the brain tissue and was not an artifact.
In addition, parasites as well as CD3+ cells were found
in the brain vasculature of resistant mice. This discrep-
ancy between these studies and those of others might be
due to methodological differences. In this study, mice
were not perfused prior to brain preparation to better
mimic the pathology observed in human brains. There-
fore, the study detected not only parasites and CD3+
cells adhering to the endothelial walls but also those cir-
culating in the brain vasculature. This might result in an
overestimation of parasite and lymphocyte load in in-
fected brains and might signify a difference in the number
of parasites and lymphocytes actively sequestered in sus-
ceptible or resistant mice. Also, while the number of para-
sites and CD3+ cells in the brains of FVB/NJ and DBA/2J
mice was comparable there could have been a difference
in the state of inflammation between the strains.
In contrast to the brain pathology, several differences
in the composition of the peripheral blood could be
discriminated over the course of the infection between
susceptible and resistant mice. A drop in circulating
lymphocytes in the peripheral blood coincided with the
accumulation of CD3+ cells in the brain of infected mice
from both strains. While the frequency of these most
common leukocytes decreased, less abundant leukocytes,
such as monocytes, increased. An increase in circulating
monocytes regardless of disease severity suggested that
they play a minor role in disease outcome in this model.
The only leukocytes that showed an inverse correlationbetween the susceptible and the resistant mice were ba-
sophils, where an increase correlated with resistance to
early disease.
ECM pathogenesis in P. berghei infection is associated
with a Th1 response involving TNF and IFN-γ cytokine
secretion while a Th2 response characterized by IL-10
and TGF-β is protective (reviewed in [47]). The pro-
tective effect of IL-10 was demonstrated by the partial
protection of susceptible mice from ECM upon adminis-
tration of IL-10; in contrast, a neutralizing anti-IL-10
antibody induced ECM in a resistant strain [48]. Baso-
phils are a central component in skewing a Th1 to a Th2
immune response by the release of IL-4 [49] which stim-
ulates the generation of IL-10 producing CD8+ T cells
[50]. The observed increase in basophil counts in the re-
sistant DBA/2J mice might therefore indicate that the
prevailing Th1 response shifted to a less harmful Th2 re-
sponse, which allows the mice to survive for an addi-
tional week. Further studies will be needed to study the
role of basophils in malaria infection.
Survival was the most robust resistance trait that dis-
tinguished the different mouse strains. While a resolving
phenotype as observed previously in DBA/2J mice, could
not be reproduced [38,45], a bimodal survival distribu-
tion was shown. A higher parasite dose used for infec-
tion might be a reason for this stronger phenotype
observed here as mice have less time to mount a pro-
tective immune response. The survival distribution in
the F2 offspring was also bimodal and mapping of the
survival trait in the F2 cross of FVB/NJ and DBA/2J
mice identified a locus on chromosome 9. This locus
overlapped partially with char1 and pymr, two loci previ-
ously identified using parasitaemia as resistance trait in
crosses between two susceptible strains, SJL and C3H/
He, and the resistant strain C57BL/6 in the P. chabaudi
and a backcross of the susceptible NC/Jic and the resis-
tant 129/SvJ in the P. yoelii model, respectively [17,43].
A region within char1 has been further prioritized by a
quantitative trait analysis of peak parasitaemia in a
C57BL/6 J and SM/J cross [25]. However, this refined re-
gion does not overlap with the locus identified here.
Even though a P. berghei model for ECM was used, the
chromosome 9 locus overlaps with two loci identified in
murine malaria models for resistance to the blood stage
form of malaria. It is, therefore, possible that the re-
sponse to the parasites in the blood is of greater import-
ance than is the response to the parasites in the brain
(in this particular strain combination). This is also in
agreement with the fact that no major differences in
brain pathologies was observed for DBA/2J and FVB/NJ
mice, but instead differences were found in the peri-
pheral blood composition.
While the markers chosen for the QTL analyses are in
regions of high genetic variability between the two mouse
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some 9 contains almost no genetic markers that are differ-
ent between FVB/NJ and DBA/2J mice (Figure 6C) and
genes in this region are unlikely candidates for the pheno-
typic differences observed between the mouse strains.
Conclusions
Mouse models are useful tools for the studies of ECM as
well as for genetic analysis of susceptibility to malaria.
The results of this study emphasize previously identified
loci involved in susceptibility or resistance to malaria.
Genes in this region, such as Rora, Irak1bp1, or Ibtk,
might be good targets for intervention studies for CM.
In addition, an association between basophils and re-
sistance to malaria early in infection was shown and
stimulating these cells might improve CM outcome in
patients.
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